Literature DB >> 15002028

Postoperative intraocular pressure spikes: the need to treat.

P Tranos1, G Bhar, B Little.   

Abstract

Raised intraocular pressure (IOP) still holds pride of place as the principal risk factor for developing glaucoma. The detrimental effects of chronically elevated IOP on the optic disc are well known. However, the clinical significance of acutely raised IOP is less certain. Transient acute elevations of intraocular pressure (IOP spikes) occur following many surgical and laser procedures. Cataract extraction, glaucoma surgery, pars plana vitrectomy with fluid air exchange, Nd-YAG capsulotomy, or peripheral iridotomy, and laser trabeculoplasty all have been reported to be associated with variable IOP spikes in the early postoperative period. There is considerable diversity of opinion concerning how these IOP spikes should best be managed. We have reviewed the nature and quality of the available experimental and clinical data relating to IOP spikes and we offer some broad, general guidelines for their clinical management.

Entities:  

Mesh:

Year:  2004        PMID: 15002028     DOI: 10.1038/sj.eye.6701319

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN: 0950-222X            Impact factor:   3.775


  15 in total

1.  Vitrectomy does not increase the risk of open-angle glaucoma or ocular hypertension--a 5-year follow-up.

Authors:  Alice L Yu; Wolfgang Brummeisl; Markus Schaumberger; Anselm Kampik; Ulrich Welge-Lussen
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2010-05-20       Impact factor: 3.117

2.  Real-Time In Vivo Intraocular Pressure Monitoring using an Optomechanical Implant and an Artificial Neural Network.

Authors:  Kun Ho Kim; Jeong Oen Lee; Juan Du; David Sretavan; Hyuck Choo
Journal:  IEEE Sens J       Date:  2017-10-05       Impact factor: 3.301

3.  Effect of 1% brinzolamide and 0.5% timolol fixed combination on intraocular pressure after cataract surgery with phacoemulsification.

Authors:  Kemal Ornek; Nesrin Büyüktortop; Nurgül Ornek; Reyhan Oğurel; Inci Elif Erbahçeci; Zafer Onaran
Journal:  Int J Ophthalmol       Date:  2013-12-18       Impact factor: 1.779

4.  Brimonidine-timolol versus brinzolamide-timolol for treatment of elevated intraocular pressure after phacoemulsification surgery.

Authors:  Selahattin Balsak; Ayhan Kaydu; Seyfettin Erdem; M Fuat Alakus; Zeynep Gursel Ozkurt
Journal:  Int Ophthalmol       Date:  2017-07-03       Impact factor: 2.031

5.  Clinical Outcomes of FP-7/8 Ahmed Glaucoma Valves in the Management of Refractory Glaucoma in the Mainland Chinese Population.

Authors:  Yingting Zhu; Yantao Wei; Xuejiao Yang; Shuifeng Deng; Zuohong Li; Fei Li; Yehong Zhuo
Journal:  PLoS One       Date:  2015-05-21       Impact factor: 3.240

6.  The Influence of a Vitrectomy on the Diurnal Intraocular Pressure.

Authors:  Yong Woo Lee; Joon Mo Kim; Seong Hee Shim; Da Yeong Kim; Jeong Hun Bae; Ki Ho Park
Journal:  J Ophthalmol       Date:  2015-06-15       Impact factor: 1.909

7.  Incidence and risk factors for intraocular pressure rise after transconjunctival vitrectomy.

Authors:  Gopal S Pillai; Rebecca Varkey; U G Unnikrishnan; Natasha Radhakrishnan
Journal:  Indian J Ophthalmol       Date:  2020-05       Impact factor: 1.848

8.  Long-term intraocular pressure changes after vitrectomy for epiretinal membrane and macular hole.

Authors:  Masato Fujikawa; Osamu Sawada; Masashi Kakinoki; Tomoko Sawada; Hajime Kawamura; Masahito Ohji
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2013-10-08       Impact factor: 3.117

Review 9.  Intraocular Pressure rise after Anti-VEGF Treatment: Prevalence, Possible Mechanisms and Correlations.

Authors:  George Kampougeris; Dimitrios Spyropoulos; Adrianna Mitropoulou
Journal:  J Curr Glaucoma Pract       Date:  2013-01-15

Review 10.  Preimplantation Flow Testing of Ahmed Glaucoma Valve and the Early Postoperative Clinical Outcome.

Authors:  Emma Jones; Pouya Alaghband; Jason Cheng; Laura Beltran-Agullo; Kin Sheng Lim
Journal:  J Curr Glaucoma Pract       Date:  2013-01-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.